| Particulars (Rupees in Crores.) | Jun-2025 | Mar-2025 | Dec-2024 | Sept-2024 | Jun-2024 |
|---|---|---|---|---|---|
Gross Sales | 669.8 | 602.6 | 596.7 | 660.2 | 601.9 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 669.8 | 602.6 | 596.7 | 660.2 | 601.9 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 28.1 | 25.8 | 25.1 | 21.9 | 20.6 |
Total Income | 697.9 | 628.4 | 621.8 | 682.1 | 622.5 |
Total Expenditure | 477.5 | 433.6 | 442.7 | 457.7 | 431.9 |
PBIDT | 220.4 | 194.8 | 179.1 | 224.4 | 190.6 |
Interest | 4.7 | 5 | 5.3 | 6 | 6 |
PBDT | 215.7 | 189.8 | 173.8 | 218.4 | 184.6 |
Depreciation | 34.6 | 36.4 | 35.5 | 35.3 | 34.7 |
Minority Interest Before NP | 0 | 0 | 0 | 0 | 0 |
Tax | 45 | 39.3 | 39.5 | 48.4 | 44.8 |
Deferred Tax | 2.1 | -41.4 | 0.7 | 3.9 | -2.7 |
Reported Profit After Tax | 134 | 155.5 | 98.1 | 130.8 | 107.8 |
Minority Interest After NP | 1.6 | 0.7 | 1.4 | 1.6 | 1.4 |
Net Profit after Minority Interest | 132.4 | 154.8 | 96.7 | 129.2 | 106.4 |
Extra-ordinary Items | 0 | 0 | 0 | 0 | 0 |
Adjusted Profit After Extra-ordinary item | 132.4 | 154.8 | 96.7 | 129.2 | 106.4 |
EPS (Unit Curr.) | 15.88 | 18.57 | 11.6 | 15.52 | 12.79 |
Book Value (Unit Curr.) | 0 | 0 | 0 | 0 | 0 |
Dividend (%) | 60 | 0 | 60 | 60 | 60 |
Equity | 83.8 | 83.6 | 83.6 | 83.6 | 83.5 |
Public Shareholding (Number) | 0 | 0 | 0 | 0 | 0 |
Public Shareholding (%) | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
PBIDTM(%) | 32.9 | 32.32 | 30.01 | 33.98 | 31.66 |
PBDTM(%) | 32.2 | 31.49 | 29.12 | 33.08 | 30.66 |
PATM(%) | 20 | 25.8 | 16.44 | 19.81 | 17.9 |
Dr Lal PathLabs declared a fourth interim dividend of ₹6 per share for 2025, reflecting its strong cash generation and shareholder remittance focus.
The company declared a third interim dividend of ₹6 per share (60% on a face value of ₹10) for FY25.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
